ZOM - Zomedica Corp. Stock Price and Quote

ZOM [AMEX]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-0.02	Insider Own	1.48%	Shs Outstand	979.95M	Perf Week	12.71%
Market Cap	285.81M	Forward P/E	-	EPS next Y	-0.17	Insider Trans	0.00%	Shs Float	965.42M	Perf Month	49.48%
Income	-17.50M	PEG	-	EPS next Q	-0.01	Inst Own	9.70%	Short Float / Ratio	9.35% / 8.89	Perf Quarter	25.01%
Sales	16.90M	P/S	16.91	EPS this Y	58.60%	Inst Trans	-2.79%	Short Interest	90.23M	Perf Half Y	-15.01%
Book/sh	0.27	P/B	1.04	EPS next Y	-750.00%	ROA	-6.30%	Target Price	6.00	Perf Year	-2.02%
Cash/sh	0.12	P/C	2.40	EPS next 5Y	-	ROE	-6.50%	52W Range	0.15 - 0.50	Perf YTD	75.71%
Dividend	-	P/FCF	-	EPS past 5Y	23.10%	ROI	-6.80%	52W High	-42.72%	Beta	0.90
Dividend %	-	Quick Ratio	17.50	Sales past 5Y	-	Gross Margin	73.70%	52W Low	90.93%	ATR	0.02
Employees	47	Current Ratio	17.80	Sales Q/Q	20665.20%	Oper. Margin	-	RSI (14)	63.90	Volatility	7.00% 10.96%
Optionable	No	Debt/Eq	0.01	EPS Q/Q	21.40%	Profit Margin	-	Rel Volume	0.55	Prev Close	0.28
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	10.14M	Price	0.29
Recom	2.00	SMA20	8.22%	SMA50	32.13%	SMA200	20.08%	Volume	883,066	Change	2.14%

Jan-06-23

Initiated

Dawson James

Buy

Jan-25-23 08:00AM	RedChip CEO Dave Gentry Invited to Join Forbes Business Council ACCESSWIRE
Jan-24-23 06:00AM	Zomedica to Participate in the Lytham Partners Investor Select Conference ACCESSWIRE
Jan-18-23 06:00AM	Zomedica to Take Control of New Assay Development and Manufacturing of TRUFORMA Product Line through Long-Term Licensing Agreement with Qorvo Biotechnologies ACCESSWIRE -8.52%
Jan-17-23 10:00AM	Sidoti's January Micro-Cap Conference ACCESSWIRE +17.01%
06:00AM	Zomedica Expands Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors ACCESSWIRE
06:00AM	Loading…
Jan-11-23 06:00AM	Zomedica to Present at Sidoti Virtual Investor Conference January 18-19 ACCESSWIRE
Dec-15-22 06:30AM	Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans ACCESSWIRE
Nov-14-22 04:20PM	Zomedica Announces Third Quarter 2022 Financial Results: $4.78 Million Revenue; 75% Gross Margin & $158.49 Million in Cash, Cash Equivalents, and Available-For-Sale Securities ACCESSWIRE
Oct-18-22 06:30AM	Zomedica to Present at LD Micro Main Event XV Conference ACCESSWIRE
Sep-28-22 06:30AM	Zomedica To Present at Dawson James Securities 7th Annual Small Cap Growth Conference ACCESSWIRE
Sep-13-22 06:30AM	Zomedica Announces Launch of Free T4 Assay for Truforma(R) Diagnostic Platform ACCESSWIRE
Sep-12-22 06:30AM	Zomedica to Present at H.C. Wainwright 24th Annual Global Investment Conference ACCESSWIRE
Sep-06-22 06:30AM	Zomedica Announces Designation of PulseVet® System as the Official Shock Wave Therapy of the National Cutting Horse Association ACCESSWIRE -9.88%
Aug-23-22 06:30AM	Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors ACCESSWIRE
Aug-15-22 05:20PM	Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million of Revenue; 71% Gross Margin & $186.8 Million in Cash; Revenue up 51% from 2021 Combined Revenues ACCESSWIRE
07:00AM	Loading…
Aug-09-22 07:00AM	Zomedica Corp. to Present at Investor Summit Group's Q3 Virtual Conference Newsfile -6.26%
Jul-18-22 06:15AM	Zomedica Acquires Assets of Leading tPEM(TM) Company Assisi Animal Health ACCESSWIRE
Jul-07-22 04:15PM	Zomedica Announces New Global Manufacturing & Distribution Center ACCESSWIRE
Jul-06-22 06:30AM	Zomedica Finalizes Acquisition of Veterinary Imaging Company Revo Squared ACCESSWIRE +13.86%
Jun-28-22 06:30AM	Zomedica Announces Designation of PulseVet(R) System as the Official Shock Wave Therapy Supplier of the United States Equestrian Team ACCESSWIRE
Jun-21-22 06:30AM	Zomedica to Participate in Panel Discussion at Animal Health Investment Forum ACCESSWIRE
Jun-15-22 06:15AM	Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo Squared ACCESSWIRE +15.24%
Jun-13-22 06:30AM	Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in Horses ACCESSWIRE
Jun-08-22 06:30AM	Zomedica to Present at JMP Securities Life Sciences Conference ACCESSWIRE
Jun-02-22 06:30AM	Karen DeHaan-Fullerton Joins Zomedica as General Counsel and Corporate Secretary ACCESSWIRE +5.76%
May-19-22 06:30AM	Zomedica Enters Into Strategic Investment and Potential Collaboration for VetGuardian Monitoring Product Line ACCESSWIRE -5.85%
May-18-22 08:00AM	Traders News Source Interviews Larry Heaton, CEO of Zomedica Corp. ACCESSWIRE
May-16-22 06:30AM	Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans ACCESSWIRE
May-10-22 04:25PM	Zomedica Announces First Quarter 2022 Revenues of $3.8 Million; 74% Gross Margin & $192.3 Million in Cash; Revenue up 38% from 2021 Combined Revenues ACCESSWIRE
May-04-22 06:30AM	Zomedica(R) Supports Feline Animal Health With American Association of Feline Practitioners' Sponsorship ACCESSWIRE
06:30AM	Loading…
Apr-27-22 06:30AM	Zomedica to Present at H.C. Wainwright Global Investment Conference ACCESSWIRE
Apr-13-22 06:30AM	Zomedica's Announces Designation of Pulsevet System as the Official Shock Wave Therapy of the American Quarter Horse Association ACCESSWIRE
Apr-04-22 06:52AM	Zomedica Announces Launch of eACTH Assay for Truforma(R) Platform ACCESSWIRE
Mar-03-22 02:05PM	Will the PulseVet Acquisition Continue to Deliver Sales for Zomedica? InvestorPlace
Mar-01-22 04:50PM	Zomedica Corporation Reports 2021 Fourth Quarter & Full Year Results ACCESSWIRE +11.00%
Feb-28-22 07:30AM	Zomedica Announces Participation in the Q1 Virtual Investor Summit Newsfile
Feb-25-22 04:20PM	Zomedica Announces Fourth Quarter and 2021 Revenues of $4.1 Million; 73.9% Gross Margin ACCESSWIRE
Feb-16-22 03:14PM	Zomedicas Shareholders Should Be Worried About the Outlook of ZOM Stock InvestorPlace +26.28%
Feb-15-22 06:05AM	Zomedica Appoints Adrian Lock to Lead Sales Organization ACCESSWIRE
Feb-09-22 06:05AM	Zomedica Announces Management Team Additions ACCESSWIRE Test RSS
06:05AM	Zomedica Announces Management Team Additions ACCESSWIRE
Jan-27-22 06:00AM	Zomedica Provides Updates on PulseVet Sales & Marketing Integration and Marketing Activities for the First Quarter of 2022 ACCESSWIRE
Jan-18-22 05:38PM	Sargent Bickham Lagudis LLC Buys iShares Core S&P 500 ETF, Vanguard FTSE Emerging Markets ... GuruFocus.com
Jan-10-22 06:30AM	Zomedica CEO Provides Update to Shareholders ACCESSWIRE
Jan-07-22 09:58AM	Theres a Reason to Consider Buying Zomedica, and Its a Real Shocker InvestorPlace
Dec-15-21 09:50AM	Zomedica to Present at H.C. Wainwright BioConnect 2022 Conference ACCESSWIRE
Dec-03-21 06:00AM	Zomedica Stock Looks Tempting Here, But Theres Likely More Downside InvestorPlace -13.16%
Nov-17-21 04:21PM	Zomedica Is Languishing Today, but Keep an Eye on This Risky Play InvestorPlace
Nov-12-21 04:10PM	Zomedica Announces Third Quarter 2021 Financial Results ACCESSWIRE
Oct-21-21 08:00AM	SPAR Group Elects Mr. Sean M. Whelan and Mr. Michael Wager to its Board of Directors GlobeNewswire
Oct-04-21 06:05AM	Zomedica Appoints Larry Heaton as President and Announces CEO Succession Plan GlobeNewswire -6.83%
Oct-01-21 06:01AM	Zomedica Acquires PulseVet GlobeNewswire +8.77%
Sep-24-21 04:35PM	With the Crickets Chirping at Zomedica HQ, Why Buy the Stock? InvestorPlace
Sep-22-21 03:00PM	Is Zomedica Stock a Buy Right Now? This Is What You Need to Know TipRanks
Sep-13-21 04:17PM	Sean Whelan Appointed to Board of Directors GlobeNewswire -5.15%
Sep-03-21 10:15AM	Zomedica Continues to Execute Poorly InvestorPlace
Aug-20-21 09:23AM	The Second Half of 2021 Should Be Much Easier for Zomedica Investors InvestorPlace
Aug-11-21 04:10PM	Zomedica Announces Second Quarter 2021 Financial Results GlobeNewswire
Jul-30-21 01:20PM	Zomedica Announces 2021 Annual Meeting Results GlobeNewswire
Jul-06-21 06:05AM	Zomedica Provides Corporate Update GlobeNewswire
Jun-06-21 08:20AM	Zomedica: Mismatch Between Valuation and Growth Profile TipRanks
May-17-21 04:05PM	Boundary Gold Begins Investigation into Lowell Schmidt, Known Nominee for Past Director and BCSC Investigation Subject David Schmidt Newsfile
06:10AM	Zomedica Hires Vice President Business Development to Lead Acquisition and Licensing Efforts GlobeNewswire
May-12-21 04:10PM	Zomedica Announces First Quarter 2021 Financial Results GlobeNewswire -8.78%
Apr-15-21 06:01AM	Zomedica to Build Direct Sales Force for TRUFORMA® Platform GlobeNewswire -13.71%
Apr-02-21 09:48AM	Pounce on This Pullback in the Zomedica Share Price InvestorPlace
Mar-16-21 06:00AM	Zomedica Announces First Commercial Sale of Its Truforma® Platform GlobeNewswire -9.24%
Mar-08-21 06:05AM	Zomedica Retires Preferred Shares GlobeNewswire +5.62%
Feb-26-21 04:15PM	Zomedica Corp. Announces Year End 2020 Financial Results GlobeNewswire
11:01AM	All Bets are Off Whether Zomedica Stock Grows Into Its Valuation InvestorPlace
10:38AM	How to Navigate the Questionable Future of the Top 10 Meme Stocks InvestorPlace
Feb-18-21 10:16AM	Here are the tough questions Congress needs to ask about GameStop today Yahoo Finance Video
Feb-16-21 12:02PM	What the GameStop Congressional hearing will reveal to retail investors Yahoo Finance -7.78%
11:37AM	Zomedica Corp. Announces Full Exercise of Over-Allotment Option by Underwriter GlobeNewswire
Feb-12-21 11:03AM	TransEnterix Stock Has Potential, But Wait for a Pullback InvestorPlace
Feb-11-21 12:18PM	Zomedica Corp. Announces Closing of $173.5 Million Bought Deal GlobeNewswire
Feb-09-21 08:16AM	Zomedica stock tumbles on heavy volume after public stock offering upsized 7-fold 'due to demand' MarketWatch -14.07%
Feb-08-21 11:00PM	Zomedica Corp. Increases Previously Announced Bought Deal Offering of Common Shares to $173.5 Million GlobeNewswire +41.36%
05:01PM	Zomedica Corp. Announces $25.0 Million Bought Deal Offering of Common Shares GlobeNewswire
Feb-05-21 04:09PM	Zomedica Is a High-Risk Trade, Not a Long-Term Investment InvestorPlace +27.33%
Feb-01-21 01:03PM	Zomedica Stock Is up 330% in One Month; Is There Room for More Upside? TipRanks +19.57%
Jan-25-21 06:10AM	Zomedica Signs TRUFORMA Distribution Agreement With Miller Veterinary Supply GlobeNewswire +6.67%
Jan-18-21 06:15AM	Zomedica CEO Issues Shareholder Letter as TRUFORMA Nears Commercialization GlobeNewswire
Jan-15-21 06:23PM	Jeremy Granthams Bubble Forecast Is an Outlier. Is He Right? Barrons.com
Jan-12-21 05:53PM	Penny stock Zomedica jumps 250% after someone paid Netflix star Carole Baskin $299 for a mention Yahoo Finance +39.78%
Jan-04-21 06:10AM	Zomedica Appoints Robert Cohen CEO as Company Nears Commercialization of TRUFORMA GlobeNewswire +51.78%
Dec-15-20 08:53AM	Zomedica to Remain Domiciled in Canada GlobeNewswire
Dec-07-20 06:01AM	Zomedica Completes Internal Launch Team for Upcoming TRUFORMA Commercialization GlobeNewswire
Nov-28-20 08:50PM	Is Zomedica Corp. (ZOM) A Good Stock To Buy Now? Insider Monkey
Nov-18-20 12:38PM	Is Zomedica Stock a Buy Right Now? This Analyst Says Yes TipRanks -12.84%
Nov-13-20 06:00AM	Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA GlobeNewswire +18.38%
Nov-12-20 06:30AM	Zomedica Announces Third Quarter 2020 Financial Results GlobeNewswire
Oct-26-20 09:25AM	Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Special Virtual-Only Meeting GlobeNewswire
Oct-02-20 05:05PM	Zomedica Announces Name Change GlobeNewswire
Sep-25-20 11:00AM	Zomedica Announces Shareholder Meeting Voting Results GlobeNewswire +5.50%
Sep-14-20 05:44PM	Zomedica Announces Letter to Shareholders in Connection With Annual and Special Virtual-Only Meeting GlobeNewswire
Sep-10-20 06:55AM	Zomedica Announces Presentation at Upcoming H.C. Wainwright Virtual Global Investment Conference GlobeNewswire
Sep-08-20 06:55AM	Zomedica to Develop Gastrointestinal Testing Panel for TRUFORMA GlobeNewswire
Aug-27-20 06:55AM	Zomedica Announces Letter From Robert Cohen, Interim CEO, Made Available to Shareholders in Connection With Annual and Special Virtual-Only Meeting GlobeNewswire
Aug-10-20 04:15PM	Zomedica Announces Second Quarter 2020 Financial Results GlobeNewswire

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience